Novel clinical trial to test if wolbachia-infected mosquitoes reduce dengue
Two UF researchers are helping to determine if spreading a bacteria among mosquitoes can suppress the incidence of dengue infections in people.
Two UF researchers are helping to determine if spreading a bacteria among mosquitoes can suppress the incidence of dengue infections in people.
Two new studies advance a potentially groundbreaking transmission-blocking malaria vaccine. UF researcher Rhoel Dinglasan's approach is completely different: Immunizing mosquitoes with malaria transmission-blocking antibodies produced in people.
A malaria vaccine designed by UF professor Rhoel Dinglasan is expected to advance to phase 1 clinical trials, thanks to new funding. The vaccine is designed differently from all others: It immunizes mosquitoes via people.
An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.
when the Ebola crisis in West Africa began capturing the world’s attention, UF biostatistics professor Ira Longini has been collaborating with a team of scientists at the World Health Organization (WHO) to develop a vaccine capable of protecting the most at-risk populations from the disease.